Fast Locator 2014-2015: AbbVie - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2014-2015: AbbVie


AbbVie
1401 Sheridan Rd
North Chicago, IL  60064

Regions served:
Globally located with plants in North America and Europe

Description:
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company¹s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world¹s most complex and serious diseases.  AbbVie Contract Manufacturing offers outsourcers access to a scientific team with a vast amount of knowledge and experience, and some of the world¹s most technically advanced facilities. 

Website
www.abbviecontractmfg.com

Services Provided:
AbbVie Contract Manufacturing
AbbVie continues a legacy of more than a century at the forefront of pharmaceutical development and manufacturing. For more than 25 years, the company has offered contract manufacturing services that today comprise biologics, potent, drug product, fermentation, prefilled syringe manufacturing and hot melt extrusion (HME), as well as selling high-quality active pharmaceutical ingredients (APIs).

The creation of AbbVie streamlined the business to solely drug development. Combining the focus of a biotech with the expertise of an established pharmaceutical leader, the contract manufacturing business is agile and flexible in its service to companies outsourcing the development and manufacture of drugs.

AbbVie Contract Manufacturing has a portfolio of 10 state-of-the-art facilities, offering a broad range of capabilities in North America and Europe. Clients are reliably served by a company with one of the industry's leading reputations for high-quality, on-time delivery. The company takes pride in its outstanding customer service record, with experienced planning and project management specialists dedicating specific time slots for contract manufacturing.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here